Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000691546 | SCV000819331 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-12-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440450 | SCV002744950 | likely benign | Cardiovascular phenotype | 2019-06-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330902 | SCV004038075 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003457736 | SCV004185488 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7 |